Xeroderma Pigmentosum
Study findings on xeroderma pigmentosum are outlined in reports from S. Zahid and colleagues
Published in Medical Letter on the CDC and FDA, June 22nd, 2008
"Understanding the molecular etiology of XP has led to the development of novel therapeutic approaches, including enzyme and gene therapies. One new topical treatment utilizing bacteriophage T4 endonuclease 5 (T4N5) in a liposomal lotion is currently in clinical trials and has received a Fast Track designation from the FDA. Gene therapy for XP, while making leaps in preclinical studies, has been slower to develop...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals - Chemotherapy
Research on chemotherapy reported by scientists at Food & Drug Administration - Depression
Research from University of Hull provide new insights into depression - Drug Resistance
Researchers at Roosevelt Hospital have published new data on drug resistance - Drug Resistance
Study Shows Copper Surfaces Kill C. Diff Bacteria - EXACT Sciences Corporation
EXACT Sciences Reports on LabCorp's Plans to Launch a New Laboratory-developed Stool-based DNA Screening Test for Colorectal Cancer in 2008 - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
